Early Access — free while we kick the tires
EdgarHawk

ABBATECOLA VINCENT P

Director

Director
2 filings analyzed · 1 company · Latest 2025-11-18

Companies

Company Buys Sells Direction
HUDSON TECHNOLOGIES INC /NY HDSN 2 0 Net buying

Activity

November 2025
low
Buy
3,500 shares
$23,748
Significance 3/10

Director Abbatecola buys 3,500 shares of HDSN at $6.78; stock down -35.3% from 52-week high and -28.0% in 90 days.

Director Vincent P. Abbatecola purchased 3,500 shares at $6.78 on 2025-11-17, increasing his holdings from 166,248 to 169,748 shares. The transaction occurs after a sustained decline: HDSN is -35.3% from its 52-week high and -28.0% over the past 90 days, with an additional -22.8% drop in the past 30 days. Abbatecola's own cross-ticker track record on buys shows poor timing: 1 prior buy with an average 90-day return of -7.3%, and his single prior trade at HDSN (a buy on 2024-11-07) also resulted in a -7.3% 90-day return. The company's fundamentals reflect contraction: annual revenue has declined -18.0% year-over-year, though current profitability ($12.4M net income on $74.0M revenue) suggests operational viability. The limited transaction size (+2.1% vs. pre-transaction holdings) and the absence of a strong pattern of well-timed insider purchases at this ticker provide minimal conviction signals.

November 2024
medium
Buy
2,500 shares
$14,948
Significance 5/10

Director Abbatecola purchases 2,500 shares of HDSN at $5.98; stock -60.0% from 52-week high

Director Vincent P. Abbatecola purchased 2,500 shares of Hudson Technologies at $5.98, expanding his holdings to 161,841 shares (+1.6% increase). The purchase occurs as the stock trades at $5.98, representing -60.0% from its 52-week high of $14.96, with a 30-day decline of -24.3%. Hudson Technologies reported recent quarterly revenue of $61,943,000.00 and net income of $7,806,000.00, though annual revenue growth stands at -11.1% versus the prior fiscal year. The stock's P/E of 8.79 and market cap of $270,287,071.86 reflect a compressed valuation, but the company's declining revenue trajectory and the timing of this purchase against the extended downtrend warrant examination of whether this transaction reveals management's internal confidence or simply reflects the director's ongoing portfolio discipline.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access